Skip to main content
. 2020 Oct 26;10:515606. doi: 10.3389/fonc.2020.515606

Table 2.

Clinicopathological characteristics of dual primary cancers patients with LCSPM between 2010 and 2015.

Variables 2010 (n = 81) 2011 (n = 230) 2012 (n = 344) 2013 (n = 436) 2014 (n = 569) 2015 (n = 625)
Age (years) 68.72 (11.44) 70.50 (10.03) 69.11 (10.60) 70.18 (9.72) 70.41 (9.60) 70.53 (9.60)
Sex
Female 37 (45.68) 90 (39.13) 127 (36.92) 148 (33.94) 212 (37.26) 263 (42.08)
Male 44 (54.32) 140 (60.87) 217 (63.08) 288 (66.06) 357 (62.74) 362 (57.92)
Histology of lung cancer
Adenocarcinoma 28 (34.57) 89 (38.70) 128 (37.21) 176 (40.37) 208 (36.56) 234 (37.44)
Squamous cell carcinomas 16 (19.75) 53 (23.04) 77 (22.38) 93 (21.33) 125 (21.97) 146 (23.36)
Small cell cancer 8 (9.88) 15 (6.52) 37 (10.76) 36 (8.26) 52 (9.14) 65 (10.40)
Others 29 (35.80) 73 (31.74) 102 (29.61) 131 (30.05) 184 (32.34) 180 (28.80)
Location of FPC
Prostate 17 (20.99) 46 (20.0) 78 (22.67) 92 (21.10) 125 (21.97) 128 (20.48)
Female Breast 17 (20.99) 29 (12.61) 39 (11.34) 55 (12.61) 72 (12.65) 96 (15.36)
Urinary Bladder 7 (8.64) 28 (12.17) 34 (9.88) 47 (10.78) 67 (11.78) 55 (8.80)
Others 40 (49.38) 127 (55.22) 193 (56.10) 242 (55.50) 305 (53.60) 346 (55.36)
Interval (months) 4.11 (2.44) 8.32 (4.99) 14.93 (9.11) 19.42 (12.34) 24.21 (15.63) 30.41 (19.84)
Stage of lung cancer
Stage I 36 (44.44) 89 (38.70) 126 (36.63) 150 (34.40) 204 (35.85) 238 (38.08)
Stage II 8 (9.88) 25 (10.87) 33 (9.59) 44 (10.09) 41 (7.21) 66 (10.56)
Stage III 11 (13.58) 45 (19.57) 77 (22.38) 71 (16.28) 107 (18.80) 103 (16.48)
Stage IV 26 (32.10) 71 (30.87) 108 (31.40) 171 (39.22) 217 (38.14) 218 (34.88)
Surgery for lung cancer
No 47 (58.02) 141 (61.3) 213 (61.92) 283 (64.91) 395 (69.42) 432 (69.12)
Yes 34 (41.98) 89 (38.7) 131 (38.08) 153 (35.09) 174 (30.58) 193 (30.88)

Continuous variables (age and interval) are presented as mean and standard deviation, and categorical variables are presented as numbers and percentages.